- Home
- ELEV vs LOCL Comparison
ELEV vs LOCL Comparison
Compare ELEV & LOCL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ELEV
- LOCL
- Stock Information
- Founded
- ELEV 2019
- LOCL 2021
- Country
- ELEV United States
- LOCL United States
- Employees
- ELEV N/A
- LOCL N/A
- Industry
- ELEV Biotechnology: Pharmaceutical Preparations
- LOCL Farming/Seeds/Milling
- Sector
- ELEV Health Care
- LOCL Consumer Staples
- Exchange
- ELEV Nasdaq
- LOCL Nasdaq
- Market Cap
- ELEV 22.6M
- LOCL 22.3M
- IPO Year
- ELEV 2021
- LOCL N/A
- Fundamental
- Price
- ELEV $0.38
- LOCL $2.56
- Analyst Decision
- ELEV Hold
- LOCL
- Analyst Count
- ELEV 6
- LOCL 0
- Target Price
- ELEV $1.77
- LOCL N/A
- AVG Volume (30 Days)
- ELEV 938.5K
- LOCL 20.1K
- Earning Date
- ELEV 08-05-2025
- LOCL 08-12-2025
- Dividend Yield
- ELEV N/A
- LOCL N/A
- EPS Growth
- ELEV N/A
- LOCL N/A
- EPS
- ELEV N/A
- LOCL N/A
- Revenue
- ELEV N/A
- LOCL $41,360,000.00
- Revenue This Year
- ELEV N/A
- LOCL $62.88
- Revenue Next Year
- ELEV N/A
- LOCL $66.75
- P/E Ratio
- ELEV N/A
- LOCL N/A
- Revenue Growth
- ELEV N/A
- LOCL 41.44
- 52 Week Low
- ELEV $0.22
- LOCL $1.18
- 52 Week High
- ELEV $3.28
- LOCL $5.75
- Technical
- Relative Strength Index (RSI)
- ELEV 54.73
- LOCL 54.27
- Support Level
- ELEV $0.36
- LOCL $2.86
- Resistance Level
- ELEV $0.38
- LOCL $3.14
- Average True Range (ATR)
- ELEV 0.01
- LOCL 0.23
- MACD
- ELEV -0.00
- LOCL 0.07
- Stochastic Oscillator
- ELEV 53.93
- LOCL 47.12
About ELEV Elevation Oncology Inc. Common stock
Elevation Oncology Inc is an oncology company focused on the development of selective cancer therapies to treat patients across a range of solid tumors with unmet medical needs. Its product candidate, EO-3021 (also known as SYSA1801 or CPO102), is an ADC comprised of a fully human anti-Claudin 18.2 immunoglobulin G1 (IgG1) monoclonal antibody (mAb) site-specifically conjugated with a cleavable linker to the cytotoxic monomethyl auristatin E (MMAE) payload. Claudin 18.2 is overexpressed in several types of cancers, including gastric, esophageal, pancreatic, ovarian and lungon.
About LOCL Local Bounti Corporation
Local Bounti Corp is a controlled environment agriculture company. Its business model is based on building local facilities, operated by local teams, to deliver fresh and quality produce to local communities while maintaining a limited carbon footprint. Using proprietary technology to grow leafy greens and herbs in smart greenhouses with a cultivation process that uses less water and land than conventional agriculture, free from herbicides or pesticides, it delivers products that have a longer shelf life, and are good in taste.